• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在随机临床试验中维护数据完整性。

Maintaining data integrity in randomized clinical trials.

作者信息

Moody Linda E, McMillan Susan

机构信息

Nursing Informatics, University of South Florida College of Nursing, Tampa, 33612, USA.

出版信息

Nurs Res. 2002 Mar-Apr;51(2):129-33. doi: 10.1097/00006199-200203000-00010.

DOI:10.1097/00006199-200203000-00010
PMID:11984384
Abstract

BACKGROUND

The process of attaining and maintaining data integrity is critical to ensure a successful randomized clinical trial. Methodologic strategies to achieve data integrity when repeated measures are used has not been discussed in detail in the literature. The National Institutes of Health requires that data integrity and safety monitoring boards or plans be established for randomized clinical trials.

OBJECTIVES

The objectives of this paper are to (a) examine important data collection issues nurse scientists often encounter in randomized clinical trials and (b) present a process that researchers can apply to achieve data integrity.

METHODS

The process to achieve data integrity is based on strategies that were developed by an interdisciplinary hospice research team involved in an ongoing National Institutes of Health-funded clinical trial. The process and key issues are illustrated with methodologic examples from the randomized clinical trial and supporting literature.

RESULTS

The process of achieving data integrity involves developing protocols in three key areas: data collection, training of data collectors, and data monitoring. The use of these protocols will increase the rigor of the clinical trial and assist in maintaining study validity.

CONCLUSIONS

Investigators conducting clinical trials need to consider all issues involved in achieving data integrity and have tested protocols in place throughout the study. These approaches will not only help maintain study validity but also help ensure data of sufficient quantity and quality to achieve the desired statistical power.

摘要

背景

获取并维持数据完整性的过程对于确保随机临床试验的成功至关重要。在使用重复测量时实现数据完整性的方法学策略在文献中尚未得到详细讨论。美国国立卫生研究院要求为随机临床试验设立数据完整性和安全监测委员会或计划。

目的

本文的目的是(a)探讨护士科学家在随机临床试验中经常遇到的重要数据收集问题,以及(b)提出一种研究人员可应用以实现数据完整性的流程。

方法

实现数据完整性的流程基于一个参与美国国立卫生研究院资助的正在进行的临床试验的跨学科临终关怀研究团队所制定的策略。通过随机临床试验中的方法学实例及相关支持文献来说明该流程及关键问题。

结果

实现数据完整性的过程涉及在三个关键领域制定方案:数据收集、数据收集者培训和数据监测。这些方案的使用将提高临床试验的严谨性,并有助于维持研究的有效性。

结论

进行临床试验的研究人员需要考虑实现数据完整性所涉及的所有问题,并在整个研究过程中实施经过测试的方案。这些方法不仅有助于维持研究的有效性,还有助于确保获得足够数量和质量的数据以达到所需的统计效能。

相似文献

1
Maintaining data integrity in randomized clinical trials.在随机临床试验中维护数据完整性。
Nurs Res. 2002 Mar-Apr;51(2):129-33. doi: 10.1097/00006199-200203000-00010.
2
American Society of Clinical Oncology policy statement: oversight of clinical research.美国临床肿瘤学会政策声明:临床研究监督
J Clin Oncol. 2003 Jun 15;21(12):2377-86. doi: 10.1200/JCO.2003.04.026. Epub 2003 Apr 29.
3
Data and safety monitoring during randomized controlled trials of nursing interventions.护理干预随机对照试验中的数据与安全监测。
Nurs Res. 2004 Nov-Dec;53(6):414-8. doi: 10.1097/00006199-200411000-00010.
4
Randomized clinical trials in medical rehabilitation research.医学康复研究中的随机临床试验。
Am J Phys Med Rehabil. 1999 Sep-Oct;78(5):486-99. doi: 10.1097/00002060-199909000-00016.
5
Limitations of randomized clinical trials in chronic diseases: explanations and recommendations.慢性病随机临床试验的局限性:解释与建议。
Adv Mind Body Med. 2002 Winter;18(2):14-21.
6
Regulatory perspectives on data safety monitoring boards: protecting the integrity of data.数据安全监测委员会的监管视角:保护数据的完整性
Drug Saf. 2004;27(1):1-6. doi: 10.2165/00002018-200427010-00001.
7
Systematic reviews of randomized controlled trials: the need for complete data.随机对照试验的系统评价:对完整数据的需求。
J Eval Clin Pract. 1995 Nov;1(2):119-26. doi: 10.1111/j.1365-2753.1995.tb00017.x.
8
Collection of health-economic data alongside clinical trials: is there a future for piggyback evaluations?在临床试验过程中收集卫生经济数据:附带评估是否有未来发展前景?
Value Health. 2005 Jan-Feb;8(1):67-79. doi: 10.1111/j.1524-4733.2005.03065.x.
9
External validity: we need to do more.外部效度:我们需要做得更多。
Ann Behav Med. 2006 Apr;31(2):105-8. doi: 10.1207/s15324796abm3102_1.
10
It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.需要注意的是,真实世界数据(RWD)永远无法取代更为传统且更为可靠的随机对照试验(RCT)数据;然而,新出现的趋势是纳入更具普遍性的数据。引言。
J Manag Care Pharm. 2011 Nov-Dec;17(9 Suppl A):S03-4.

引用本文的文献

1
Recruitment and retention of older adolescent and young adult female survivors of childhood cancer in longitudinal research.在纵向研究中招募和留住儿童癌症的大龄青少年及年轻成年女性幸存者。
Oncol Nurs Forum. 2012 Sep;39(5):483-90. doi: 10.1188/12.ONF.483-490.
2
Measuring the Quality of Data Collection in a Large Observational Cohort of HIV and AIDS.评估一个大型艾滋病毒和艾滋病观察队列中数据收集的质量。
Open AIDS J. 2010 May 5;4:96-102. doi: 10.2174/1874613601004010096.